FIRENDIA-10 mg contains Finerenone 10 mg. It is a non-steroidal mineralocorticoid receptor antagonist (MRA) medicine used to reduce kidney and cardiovascular complications in certain patients with chronic kidney disease associated with type 2 diabetes.
Uses:
-
Treatment of chronic kidney disease (CKD) associated with type 2 diabetes mellitus
-
Helps slow the progression of kidney disease
-
Reduces the risk of cardiovascular events such as heart failure hospitalization in eligible patients
-
Helps protect kidney and heart function
Dose:
-
Adults: Usually 10 mg once daily as an initial dose or as directed by a physician
-
Dose may be increased to 20 mg once daily based on kidney function and blood potassium levels
-
Can be taken with or without food
-
Regular monitoring of kidney function and potassium levels is required
-
Follow the prescribed dose and duration as advised by a healthcare professional